| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/15/2011 | US7888464 Hepatitis C virus inhibitors |
| 02/15/2011 | US7888463 Modulators of antiestrogen pharmacology |
| 02/15/2011 | US7888461 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching |
| 02/15/2011 | US7888459 reaction to achieve facile covalent cross-linking of proteins by lyophilizing protein or proteins with compounds containing two or more reducing sugars separated by a linker; colyophilization of a protein with a reducing sugar |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888430 Pulverized silk fibroin for enhancing paints, inks, fiber treatment agents, rubbers, plastic molded products and synthetic leather |
| 02/15/2011 | US7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 02/15/2011 | US7888324 Antisense modulation of apolipoprotein B expression |
| 02/15/2011 | US7888323 Potent compstatin analogs |
| 02/15/2011 | US7888322 Use of VEGF and homologues to treat neuron disorders |
| 02/15/2011 | US7888321 Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses |
| 02/15/2011 | US7888320 Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| 02/15/2011 | US7888319 using a polypeptide comprising a carboxy-terminal amino acid sequence of an alpha Connexin; reduces scar formation |
| 02/15/2011 | US7888318 Method of preparing an organ by perfusion |
| 02/15/2011 | US7888317 Glucagon-like peptide-2 and its therapeutic use |
| 02/15/2011 | US7888316 Polypeptide films and methods |
| 02/15/2011 | US7888315 Use of aspartic proteases in cosmetics and therapeutics |
| 02/15/2011 | US7888314 Compositions and methods for treating peripheral vascular disease |
| 02/15/2011 | US7888313 Composition for treating a fibrotic disorder comprising an inhibitor of a BMP-1-like protein |
| 02/15/2011 | US7888312 Method of treating periodontal diseases by administering a therapeutically effective amount of GM-CSF |
| 02/15/2011 | US7888311 for decontaminating soils and water; for detecting and treating people contaminated by uranium |
| 02/15/2011 | US7888115 Major histocompatibility complex amino acid sequences for use as tool in developing antibodies and vaccine for use in prevention and treatment of cell proliferative disorders; immunotherapy |
| 02/15/2011 | US7888114 encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations; for gene therapy, cancer |
| 02/15/2011 | US7888094 Nucleotide sequences coding prolyl dipeptidyl peptidase for use as tool in identifying modulators for prevention and treatment of activity neoplasia, type II diabetes, cirrhosis, autoimmunity, graft rejection and HIV infection |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7888089 Nucleotide sequences coding polypeptide for use in the treatment of cardivascular, restenosis, hypertension, atherosclerosis, heart defects, diabetes and neovascularization disorders; endothelial nitric oxide synthase (eNOS) |
| 02/15/2011 | US7888076 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888070 in which the RSP sorting signal has been mutated such that the GH can be constitutively secreted by the nonregulated secretory pathway (NRSP) in a mammalian cell |
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7888047 PDEs as modifiers of the IGFR pathways and methods of use |
| 02/15/2011 | US7888038 modulating apoptosis-induced cell death comprising modulating the level of Bak Binding Protein (BBP) in a eukaryotic cell; drug screening |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887831 comprising synthetic apatite and supplementary bioactive agent such as biocompatible polysaccharide and anti-resorptive agent added ab initio; for treating orthopedic, periodontal and craniofacial indications |
| 02/15/2011 | US7887815 Peptide diagnostic agent for lyme disease |
| 02/15/2011 | US7887814 binding proteins, fused with transferrins; for treatment of Alzheimer's, Down Syndrome, infant encephalitis, AIDS, and autoimmune diseases |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887800 activating endothelial growth factors VEGF-C or vascular endothelial growth factor D (VEGF-D) with plasmin; Angiogenesis |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887798 Methods of treating cancer by administering antibodies to CD200 |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | US7887572 An implantable device having a bioactive pattern of pores loaded with protein of fibronectin, laminin 5, elastin, silk elastin, or collagen bonded by a spacer to an endothelialization promoter to form a biological conjugate; tissue engineering; stents; heart valves; vascular systems; drug delivery |
| 02/15/2011 | CA2633072C Analgesic compounds and process of manufacture |
| 02/15/2011 | CA2519993C Ph-dependent polypeptide aggregation and its use |
| 02/15/2011 | CA2491172C Microcapsules for the delayed, controlled release of perindopril |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2451043C Enhanced drug delivery in transdermal systems |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2361364C Dalda analogs and their use |
| 02/15/2011 | CA2356701C Gene therapy for diabetic ischemic disease |
| 02/15/2011 | CA2334863C Antithrombotic compounds |
| 02/15/2011 | CA2311679C Use of a soluble recombinant human cd40l protein for inhibiting in vivo immune response |
| 02/15/2011 | CA2311389C Antimicrobial peptides |
| 02/15/2011 | CA2295332C Aib1, a novel steroid receptor co-activator |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2286397C Humanized antibodies and methods for forming humanized antibodies |
| 02/15/2011 | CA2263647C Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 02/15/2011 | CA2247420C Combination therapy for osteoporosis |
| 02/15/2011 | CA2196304C Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/15/2011 | CA2189691C Novel tetrapeptides, their preparation and use |
| 02/10/2011 | WO2011017564A2 Identification and use of compounds for treating persistent pain |
| 02/10/2011 | WO2011017554A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 02/10/2011 | WO2011017502A2 Linaclotide-containing formulations for oral administration |
| 02/10/2011 | WO2011017335A1 Swallowable capsule and method for stimulating incretin production within the intestinal tract |
| 02/10/2011 | WO2011017209A1 Use of melanocortins to treat dyslipidemia |
| 02/10/2011 | WO2011017177A1 Compositions and methods for treating gaucher disease |
| 02/10/2011 | WO2011017162A2 Methods for enhancing antigen-specific immune responses |
| 02/10/2011 | WO2011017160A1 Mutant human interferon proteins and genes |
| 02/10/2011 | WO2011017159A2 Broad spectrum erbb ligand binding molecules and methods for preparing and using them |
| 02/10/2011 | WO2011017132A2 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 02/10/2011 | WO2011017107A2 Microbubble assisted viral delivery |
| 02/10/2011 | WO2011017070A1 Methods for producing high concentration lyophilized pharmaceutical formulations |
| 02/10/2011 | WO2011016861A2 Novel regulatory proteins and inhibitors |
| 02/10/2011 | WO2011016840A2 Methods and compositions for treating trinucleotide repeat disorders |
| 02/10/2011 | WO2011016534A1 Plasma protein having antitussive effect |
| 02/10/2011 | WO2011016220A1 Dipeptidyl peptidase-4 inhibitor |
| 02/10/2011 | WO2011016026A2 Novel proteins |
| 02/10/2011 | WO2011015984A1 Orally administerable pharmaceutical preparation containing insulin |
| 02/10/2011 | WO2011015683A1 Use of inhibitors of adam-17 for neuronal regeneration |
| 02/10/2011 | WO2011014990A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof |
| 02/10/2011 | WO2011014925A1 Process for obtaining peptide fractions |
| 02/10/2011 | WO2010146578A3 Peptide therapy for increasing platelet levels |
| 02/10/2011 | WO2010124280A3 Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034898 Stable Formulation of a Therapeutic Protein |
| 02/10/2011 | US20110034752 Therapeutic regimen for treating cancer |
| 02/10/2011 | US20110034737 Water-Soluble Polymer Alkanals |
| 02/10/2011 | US20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 02/10/2011 | US20110034401 Novel process for solubilizing protein from a proteinaceous material and compositions thereof |
| 02/10/2011 | US20110034400 Compositions and methods for analyzing bacterial adherence and anti-adherence to mucus, epithelial cells and other cells |
| 02/10/2011 | US20110034399 Liquid and Freeze Dried Formulations |